Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Hypobetalipoproteinemia, Familial, Apolipoprotein B MeSH Descriptor Data 2025
An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.
Entry Term(s)
Abetalipoproteinemia, Normotriglyceridemic, Steinbert Type
Apolipoprotein B Deficiency
Apolipoprotein B Deficiency Disease
Hypobetalipoproteinemia, Familial, Apo B
Previous Indexing
Apolipoproteins B (1986-2006)
Public MeSH Note
2007; for APOLIPOPROTEIN B DEFICIENCY DISEASE see ABETALIPOPROTEINEMIA 2000-2006
History Note
2007; for APOLIPOPROTEIN B DEFICIENCY DISEASE use ABETALIPOPROTEINEMIA 2000-2006
An autosomal dominant disorder of lipid metabolism. It is caused by mutations of APOLIPOPROTEINS B, main components of CHYLOMICRONS and BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include abnormally low LDL, normal triglyceride level, and dietary fat malabsorption.